Status | Study |
Recruiting |
Study Name: A Study of Nab-paclitaxel-based Doublet as First Line Therapy in Patients With Cancer of Unknown Primary (CUP) Condition: Unknown Primary Tumors Date: 2015-11-16 Interventions: Drug: nab-paclitaxel Other Nam |
Recruiting |
Study Name: Phase 2 Study of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Carcinoma of Unknown Primary Condition: Carcinoma of Unknown Primary Date: 2015-10-27 Interventions: Drug: gemcitabine/docetaxel combination |
Completed |
Study Name: Prospective Multi-center, Single Blinded, Randomized, Controlled Trial of EUS-FNB and EUS-FNA on Solid Occupying Lesion Condition: Pancreas Neoplasms Lymphatic Metastasis Neoplasm Metastase Date: 2014-12-11 Interventions: Device: EUS-FNA (EchoTip Ultra) |
Recruiting |
Study Name: Trial Comparing a Strategy Based on Molecular Analysis to the Empiric Strategy in Patients With CUP Condition: Neoplasms, Unknown Primary Date: 2012-02-13 Interventions: Other: Cancer Type ID test |
Completed |
Study Name: Cost-effectiveness Study of miRview™ Mets in Patients With Cancer of Unknown Primary (CUP) Condition: Neoplasms, Unknown Primary Date: 2010-09-14 |
Completed |
Study Name: Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary Condition: Carcinoma of Unknown Primary Origin Date: 2009-07-08 Interventions: Drug: carboplatin Given IV |
Completed |
Study Name: Paclitaxel/Carboplatin With or Without Cetuximab in CUP Condition: Neoplasms, Unknown Primary Carcinoma Date: 2009-05-06 Interventions: Drug: paclitaxel/carboplatin 6 |
Completed |
Study Name: Review of Molecular Profiling-Real Time Polymerase Chain Reaction (Rt-Pcr) in Unknown Primary Cancer Condition: Unknown Primary Cancer Date: 2009-04-03 |
Completed |
Study Name: Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary Condition: Carcinoma of Unknown Primary Date: 2009-03-31 Interventions: Drug: belinostat, carboplatin, paclitaxel |
Completed |
Study Name: Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site Condition: Carcinoma Date: 2008-08-15 Interventions: Drug: Paclitaxel 175 mg/m2, 1- |